Lµbris BioPharma is a biopharmaceutical company developing recombinant human lubricin for the treatment of dry eye, osteoarthritis and other age & inflammation-related conditions.

Lubricin functions like biologic Teflon® – it is naturally produced throughout the human body protecting tissues and other surfaces from friction-related damage and wear.

Supplementation with recombinant human lubricin is an innovative and exciting new approach to disease management.


Novartis to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications
Read more>

Lubris Biopharma announces out-licensing of its proprietary recombinant human lubricin for use in ophthalmology to major pharma company.
Read more>

Lubris Biopharma announces positive results of a clinical trial demonstrating significant improvement in both signs and symptoms of dry eye disease.
Learn more >

Discovery of ‘Mother Nature’s lubricant’ leads biomedical researcher to explore new health applications
Learn more >

New research shows potential role of lubricin in reducing inflammation in osteoarthritis.
Ann Phys Rehabil Med. 2016 Jun;59(3):149-56
Sci Rep. 2016 Jan 11;6:18910